Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990–2023: Evidence from the Global Burden of Disease Study 2023
Cancers · 03.11.2026 · 18 (21) · 3535
DOI: 10.3390/cancers18213535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 03.11.2026. Verfasst von Lanwei Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trials Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Clinical Medical Scientist Program, Investigator-initiated Clinical Trial and Transformation of Scientific Achievements, Henan Cancer Hospital, Henan Province Program for Cultivating Leading Talents in Science and Technology Innovation in Health and Medicine Among Middle-Aged and Young Professionals.
Abstract (Originalsprache)
Background
Gastrointestinal cancers are among the leading causes of cancer incidence and mortality worldwide and represent a major contributor to the cancer burden in Asia. This study aims to assess the burden of six major gastrointestinal cancers in Asia from 1990 to 2023.
Methods
Based on the Global Burden of Disease 2023 data, we analyzed the incidence, mortality, and disability-adjusted life years (DALYs) of six major gastrointestinal cancers—esophageal cancer (EC), stomach cancer (SC), colon and rectum cancer (CRC), liver cancer (LC), pancreatic cancer (PC), and gallbladder and biliary tract cancer (GBTC)—from 1990 to 2023.
Results
In 2023, Asia reported about 3.23 million new gastrointestinal cancer cases and 2.26 million deaths, resulting in 55.10 million DALYs. EC had the highest burden in East Asia [age-standardized incidence rate (ASIR): 11.41 per 100,000; age-standardized death rate (ASDR): 10.88 per 100,000; age-standardized DALY rate (ASDALYR): 244.41 per 100,000], while CRC, PC, and GBTC had a high burden in the high-income Asia-Pacific region. From 1990 to 2023, EC, LC, and GBTC declined in most regions, whereas PC increased except in East Asia. The burden was generally higher in males; however, in South Asia, females had higher ASIR (3.35 per 100,000), ASDR (3.44 per 100,000), and ASDALYR (82.94 per 100,000) for GBTC than males.
Conclusions
The burden of gastrointestinal cancer in Asia is heavy and unevenly distributed; in the future, more targeted regional prevention and control strategies should be implemented based on socioeconomic levels and the characteristics of the disease spectrum.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Trials Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
- Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, China.
- Center for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Unio…
ORCID-Profile: Lanwei Guo
Förderung
- Henan Clinical Medical Scientist Program
- Investigator-initiated Clinical Trial and Transformation of Scientific Achievements, Henan Cancer Hospital
- Henan Province Program for Cultivating Leading Talents in Science and Technology Innovation in Health and Medicine Among Middle-Aged and Young Professionals
Zitieren
APA
Guo, L., Zhu, C., Yuan, J., Cai, L., Luan, H., Chen, H., Zheng, Y., & Liu, Y. (2026). Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990–2023: Evidence from the Global Burden of Disease Study 2023. Cancers, 18(21), 3535. https://doi.org/10.3390/cancers18213535
Vancouver
Guo L, Zhu C, Yuan J, Cai L, Luan H, Chen H, et al. Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990–2023: Evidence from the Global Burden of Disease Study 2023. Cancers. 2026;18(21):3535. doi:10.3390/cancers18213535
BibTeX
@article{Guo2026,
author = {Guo, Lanwei and Zhu, Chenxin and Yuan, Jiani and Cai, Lin and Luan, Huamei and Chen, Hongda and Zheng, Yan and Liu, Yanyan},
title = {Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990–2023: Evidence from the Global Burden of Disease Study 2023},
journal = {Cancers},
year = {2026},
volume = {18},
number = {21},
pages = {3535},
doi = {10.3390/cancers18213535}
}
EUVIMED